NSD2 and neoplasm: Contrary to loss-of-function NSD1 mutations in cancers, which suggest a tumor suppressor function, NSD2 has emerged as an oncogenic gene with elevated expression or hyperactive mutations in multiple human cancers, including colorectal, prostate, and lung cancers.